Literature DB >> 19225914

High prevalence of restless legs syndrome among patients with polycytemia vera treated with venesectio.

Magnus Tobiasson1, Bassam Alyass, Susanne Söderlund, Gunnar Birgegård.   

Abstract

In order to examine whether symptoms of iron deficiency anemia are due to the iron deficiency itself or the associated anemia, 34 patients with polycytemia vera (PV) treated with venesectio, who had iron deficiency but normal hemoglobin (Hb) levels, were given a questionnaire covering symptoms of iron deficiency including the international RLS-scale and the Fact-fatigue quality of life scale (QoL). We found a prevalence of pica of 11.7%, mouth paresthesias of 5.8% and rest-less legs 29.6% (RLS "normal" prevalence 10%). Thus, the prevalence of RLS is significantly higher in our population. We also saw a significant difference in QoL between patients with and without RLS (P = 0.015) and QoL correlated with the severity of RLS (R = 0.85). In conclusion, RLS seems to be a frequent and serious problem for PV patients treated with venesectio according to standard guidelines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225914     DOI: 10.1007/s12032-009-9180-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  12 in total

1.  Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.

Authors:  Mary F McMullin; John T Reilly; Peter Campbell; David Bareford; Anthony R Green; Claire N Harrison; Eibhlin Conneally; Kate Ryan
Journal:  Br J Haematol       Date:  2007-08-02       Impact factor: 6.998

2.  Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera.

Authors:  Jean-Jacques Kiladjian; Bruno Cassinat; Sylvie Chevret; Pascal Turlure; Nathalie Cambier; Murielle Roussel; Sylvia Bellucci; Bernard Grandchamp; Christine Chomienne; Pierre Fenaux
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

3.  Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia.

Authors:  Anne Ricksten; Lars Palmqvist; Peter Johansson; Björn Andreasson
Journal:  Haematologica       Date:  2008-06-02       Impact factor: 9.941

4.  Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study.

Authors:  F Tison; A Crochard; D Léger; S Bouée; E Lainey; A El Hasnaoui
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

5.  The relationship between iron status and thyroid hormone concentration in iron-deficient adolescent Iranian girls.

Authors:  Mohammad Hassan Eftekhari; Seyed Ali Keshavarz; Mahmood Jalali; Eric Elguero; Mohammad R Eshraghian; Kirsten B Simondon
Journal:  Asia Pac J Clin Nutr       Date:  2006       Impact factor: 1.662

6.  Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries.

Authors:  Bjørn Bjorvatn; Lena Leissner; Jan Ulfberg; Jens Gyring; Merete Karlsborg; Lisbeth Regeur; Håvard Skeidsvoll; Inger Hilde Nordhus; Ståle Pallesen
Journal:  Sleep Med       Date:  2005-07       Impact factor: 3.492

7.  Restless Legs Syndrome among working-aged women.

Authors:  J Ulfberg; B Nyström; N Carter; C Edling
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

8.  Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Authors:  S B Yellen; D F Cella; K Webster; C Blendowski; E Kaplan
Journal:  J Pain Symptom Manage       Date:  1997-02       Impact factor: 3.612

9.  Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort.

Authors:  John W Winkelman; Laurel Finn; Terry Young
Journal:  Sleep Med       Date:  2006-06-05       Impact factor: 3.492

Review 10.  Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).

Authors:  Richard Allen
Journal:  Sleep Med       Date:  2004-07       Impact factor: 3.492

View more
  6 in total

1.  Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

Authors:  Alessandro M Vannucchi; Jean Jacques Kiladjian; Martin Griesshammer; Tamas Masszi; Simon Durrant; Francesco Passamonti; Claire N Harrison; Fabrizio Pane; Pierre Zachee; Ruben Mesa; Shui He; Mark M Jones; William Garrett; Jingjin Li; Ulrich Pirron; Dany Habr; Srdan Verstovsek
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

Review 2.  How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera.

Authors:  Andreas Reiter; Claire Harrison
Journal:  Curr Hematol Malig Rep       Date:  2016-10       Impact factor: 3.952

3.  The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts.

Authors:  Robyn Marie Scherber; Holly Lynn Geyer; Amylou C Dueck; Heidi E Kosiorek; Guido Finazzi; Riccardo Cavazzina; Arianna Masciulli; Marco Scarano; Alessandro M Vannucchi; Ruben A Mesa; Tiziano Barbui
Journal:  Leuk Lymphoma       Date:  2016-11-10

Review 4.  Iron in Restless Legs Syndrome.

Authors:  Eva C Schulte; Maria Kaffe; Barbara Schormair; Juliane Winkelmann
Journal:  Mov Disord Clin Pract       Date:  2014-06-12

5.  Individuals with Restless Legs Syndrome Tend to have Severe Depressive Symptoms: Findings from a Community-Based Cohort Study.

Authors:  Chul-Hyun Cho; Leen Kim; Heon-Jeong Lee
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

6.  Pica for Uncooked Basmati Rice in Two Women with Iron Deficiency and a Review of Ryzophagia.

Authors:  James C Barton; J Clayborn Barton; Luigi F Bertoli
Journal:  Case Rep Med       Date:  2016-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.